Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 190.43

-0.7%

Feb 6 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: squetch who wrote (11918)	12/1/1997 8:50:00 AM
From: Henry Niman	Read Replies (1) of 32384

Stan, CNBC is talking about Rezulin. GLX has decided to stop selling it in Great Britain pending safety review. WLA has relabeled the drug (to include liver function tests) as has Sankyo in Japan (and they are also continuing with sales). However, the GLX decision to stop selling the drug in Great Britain is hitting WLA's stock price hard (down 11 in instanet trading).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next